Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -146.30%-822.19M | ---- | -75.89%1.78B | ---- | 101.95%7.37B | ---- | -55.15%3.65B | ---- | 21.68%8.13B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -51.02%-383.38M | ---- | 32.85%-253.86M | ---- | -8.06%-378.07M | ---- | 0.64%-349.86M | ---- | -61.53%-352.1M |
| Dividend (income)- adjustment | ---- | 0.78%-2.15M | ---- | -3.73%-2.17M | ---- | -2.65%-2.09M | ---- | 99.87%-2.04M | ---- | -89,030.90%-1.63B |
| Attributable subsidiary (profit) loss | ---- | 66.31%1.14B | ---- | 274.41%682.7M | ---- | 53.59%-391.44M | ---- | 32.75%-843.45M | ---- | 38.69%-1.25B |
| Impairment and provisions: | ---- | 1,796.12%1.49B | ---- | -75.80%78.41M | ---- | -1.62%324.03M | ---- | 185.10%329.35M | ---- | 299.07%115.52M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --117.43M |
| -Impairmen of inventory (reversal) | ---- | 493.18%306.73M | ---- | -79.06%51.71M | ---- | 405.91%246.89M | ---- | ---80.71M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -77.28%4.05M | ---- | -68.15%17.84M | ---- | 1,058.20%56M | ---- | -77.99%4.84M | ---- | 32.12%21.97M |
| -Other impairments and provisions | ---- | 13,170.60%1.18B | ---- | -58.08%8.86M | ---- | -94.78%21.14M | ---- | 1,797.60%405.22M | ---- | -293.70%-23.87M |
| Revaluation surplus: | ---- | 145.16%216.62M | ---- | -167.77%-479.63M | ---- | -89.56%707.73M | ---- | 491.33%6.78B | ---- | 178.24%1.15B |
| -Fair value of investment properties (increase) | ---- | 141.08%227.88M | ---- | -257.62%-554.65M | ---- | -13.25%351.89M | ---- | -40.09%405.65M | ---- | 148.61%677.13M |
| -Other fair value changes | ---- | -115.00%-11.25M | ---- | -78.92%75.03M | ---- | -94.42%355.85M | ---- | 1,257.87%6.37B | ---- | 748.56%469.43M |
| Asset sale loss (gain): | ---- | -104.47%-175K | ---- | 316.23%3.92M | ---- | -536.39%-1.81M | ---- | -75.34%415K | ---- | 129.92%1.68M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -104.47%-175K | ---- | 316.23%3.92M | ---- | -536.39%-1.81M | ---- | -75.34%415K | ---- | 129.92%1.68M |
| Depreciation and amortization: | ---- | 2.92%413.58M | ---- | -10.89%401.85M | ---- | 20.51%450.97M | ---- | 54.66%374.2M | ---- | 2.24%241.95M |
| -Depreciation | ---- | 2.92%413.58M | ---- | -10.89%401.85M | ---- | 20.51%450.97M | ---- | 54.66%374.2M | ---- | 2.73%241.95M |
| Financial expense | ---- | 10.97%1.38B | ---- | 28.12%1.24B | ---- | 31.77%971.69M | ---- | -25.67%737.39M | ---- | 76.77%992.04M |
| Special items | ---- | -83.41%38K | ---- | -66.12%229K | ---- | -80.43%676K | ---- | 109.22%3.46M | ---- | -179.48%-37.48M |
| Operating profit before the change of operating capital | ---- | -0.76%3.43B | ---- | -61.85%3.45B | ---- | -15.25%9.05B | ---- | 45.06%10.68B | ---- | 95.37%7.36B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -71.07%20.4M | ---- | 169.46%70.51M | ---- | -25.00%-101.51M | ---- | -536.14%-81.2M | ---- | 128.13%18.62M |
| Developing property (increase)decrease | ---- | 976.78%9.93B | ---- | 103.92%921.94M | ---- | -163.80%-23.5B | ---- | 42.72%-8.91B | ---- | -516.16%-15.55B |
| Accounts receivable (increase)decrease | ---- | 79.49%765.4M | ---- | 129.88%426.43M | ---- | -1,601.89%-1.43B | ---- | -107.52%-83.85M | ---- | 183.22%1.11B |
| Accounts payable increase (decrease) | ---- | -222.88%-844.82M | ---- | -93.41%687.51M | ---- | 325.74%10.43B | ---- | 235.81%2.45B | ---- | 406.58%729.43M |
| prepayments (increase)decrease | ---- | 124.91%596.24M | ---- | -9,035.67%-2.39B | ---- | -102.31%-26.21M | ---- | 230.11%1.14B | ---- | -16.58%-873.23M |
| Special items for working capital changes | ---- | -254.34%-11.86B | ---- | 992.22%7.68B | ---- | 88.60%-861.04M | ---- | -206.73%-7.55B | ---- | -8.14%7.08B |
| Adjustment items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10M |
| Cash from business operations | 1,602.64%5.97B | -81.26%2.03B | -88.62%350.44M | 268.42%10.85B | 118.86%3.08B | -172.26%-6.44B | -734.78%-16.33B | -1,941.69%-2.37B | -58.49%2.57B | -101.40%-115.86M |
| Other taxs | -211.63%-3.18B | 38.76%-2.04B | 32.27%-1.02B | 36.40%-3.32B | 42.90%-1.51B | -38.66%-5.23B | 0.27%-2.64B | -50.93%-3.77B | -70.83%-2.65B | ---2.5B |
| Interest received - operating | -46.44%43.44M | -9.30%241.13M | -4.58%81.1M | 25.29%265.85M | -35.48%85M | -68.01%212.19M | 22.56%131.73M | --663.27M | --107.48M | ---- |
| Interest paid - operating | -15.87%-1.19B | 38.82%-2.07B | -14.55%-1.03B | -90.10%-3.39B | -57.25%-895.44M | -49.97%-1.78B | -22.79%-569.44M | 12.97%-1.19B | 22.51%-463.76M | -8.13%-1.37B |
| Net cash from operations | 201.43%1.64B | -141.77%-1.84B | -312.63%-1.62B | 133.21%4.4B | 103.92%759.81M | -98.74%-13.24B | -4,382.51%-19.4B | -67.36%-6.66B | -110.70%-432.89M | -199.22%-3.98B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -99.20%84K | ---- | -52.11%10.52M | ---- | 1,160.41%21.97M | ---- | -96.36%1.74M | ---- | -41.42%47.93M | 126.53%350.12M |
| Dividend received - investment | ---- | 261.29%93.7M | -99.14%70K | -69.21%25.93M | -91.30%8.09M | -54.12%84.24M | -34.32%93.03M | -93.78%183.6M | -88.81%141.65M | 636.44%2.95B |
| Loan receivable (increase) decrease | 77.53%-60.09M | 74.85%-178.78M | -116.25%-267.49M | -153.11%-710.72M | 48.72%-123.7M | 2,203.96%1.34B | -41.55%-241.22M | 103.82%58.09M | 79.63%-170.42M | -133,672.56%-1.52B |
| Sale of fixed assets | ---- | -16.50%172K | -53.70%50K | 320.41%206K | 468.42%108K | -19.67%49K | -54.76%19K | -99.39%61K | -40.00%42K | 34.89%10.03M |
| Purchase of fixed assets | -53.08%-165.62M | -108.96%-926.33M | 15.19%-108.19M | 56.59%-443.3M | -64.17%-127.56M | -189.04%-1.02B | -18.54%-77.7M | -17.97%-353.33M | 30.91%-65.55M | 45.73%-299.51M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.61%1.15M | ---11.83M | --48.24M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4,988.62%-568.04M |
| Recovery of cash from investments | ---- | ---- | ---- | --2.41B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | -29.41%-105.31M | 58.95%-381.64M | 47.60%-81.38M | -906.86%-929.61M | -224.26%-155.32M | -57.82%-92.33M | ---47.9M | 89.43%-58.5M | ---- | 10.52%-553.7M |
| Net cash from investment operations | 25.87%-330.94M | -494.32%-1.39B | -18.60%-446.42M | 14.33%353.24M | -38.37%-376.4M | 282.89%308.95M | -367.62%-272.02M | -140.00%-168.93M | 88.40%-58.17M | 139.11%422.34M |
| Net cash before financing | 163.42%1.31B | -167.98%-3.23B | -637.79%-2.06B | 136.73%4.75B | 101.95%383.42M | -89.30%-12.93B | -3,906.91%-19.68B | -91.97%-6.83B | -113.85%-491.06M | -184.95%-3.56B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 42.71%13.37B | -35.60%22.16B | -52.40%9.37B | -25.19%34.41B | -44.21%19.69B | -9.63%46B | 33.32%35.29B | 75.83%50.9B | 87.34%26.47B | 63.72%28.95B |
| Refund | -47.48%-15.59B | 39.40%-23.12B | 47.61%-10.57B | -2.91%-38.15B | -29.88%-20.18B | 5.60%-37.07B | 33.36%-15.54B | -124.36%-39.26B | -136.80%-23.31B | 17.58%-17.5B |
| Dividends paid - financing | 81.47%-6.19M | 47.02%-750.65M | ---33.38M | -19.78%-1.42B | ---- | 54.02%-1.18B | ---- | -38.69%-2.57B | 9.85%-4.78M | -250.79%-1.85B |
| Absorb investment income | ---- | 19.06%6.48M | 19.87%6.61M | -52.29%5.44M | -46.12%5.51M | -98.15%11.4M | 248.33%10.23M | --617.54M | --2.94M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---1.85M | ---1.86M | ---- | ---- | ---- |
| Net cash from financing operations | -76.77%-2.26B | 65.13%-1.82B | -138.24%-1.28B | -168.74%-5.22B | -102.73%-537.46M | -20.34%7.59B | 533.46%19.7B | 0.57%9.52B | -26.21%3.11B | 330.08%9.47B |
| Effect of rate | 208.40%84.77M | -48.10%-219.98M | -5.78%-78.2M | 94.89%-148.54M | 91.88%-73.92M | -374.95%-2.91B | -480.25%-910.88M | 75.91%1.06B | 255.68%239.55M | 339.05%600.78M |
| Net Cash | 71.41%-955.68M | -983.54%-5.05B | -2,069.79%-3.34B | 91.28%-465.87M | -740.47%-154.05M | -298.34%-5.34B | -99.08%24.05M | -54.44%2.69B | -66.25%2.62B | 8,074.16%5.91B |
| Begining period cash | -47.66%5.79B | -5.27%11.05B | -5.27%11.05B | -41.42%11.67B | -41.42%11.67B | 23.20%19.92B | 23.20%19.92B | 67.47%16.17B | 67.47%16.17B | -1.82%9.65B |
| Cash at the end | -35.61%4.92B | -47.66%5.79B | -33.28%7.63B | -5.27%11.05B | -39.88%11.44B | -41.42%11.67B | 0.03%19.03B | 23.20%19.92B | 10.23%19.02B | 67.47%16.17B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.